DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Macdonald RL. et al.
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).
Lancet Neurol 2011;
10: 618-25.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.